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Global gene expression proﬁling of
JMJD6- and JMJD4-depleted mouse
NIH3T3 ﬁbroblasts
Yu-Jie Hu1 & Anthony N. Imbalzano1
Emerging evidence suggests Jumonji domain-containing proteins are epigenetic regulators in diverse
biological processes including cellular differentiation and proliferation. RNA interference-based analyses
combined with gene expression proﬁling can effectively characterize the cellular functions of these
enzymes. We found that the depletion of Jumonji domain-containing protein 6 (JMJD6) and its paralog
protein Jumonji domain-containing protein 4 (JMJD4) individually by small hairpin RNAs (shRNAs)
slowed cell proliferation of mouse NIH3T3 ﬁbroblasts. We subsequently performed gene expression
proﬁling on both JMJD6- and JMJD4-depleted mouse NIH3T3 ﬁbroblasts using the Affymetrix GeneChip
Mouse Exon 1.0 ST Array. Here we report the gene proﬁling datasets along with the experimental
procedures. The information can be used to further investigate how JMJD6 and JMJD4 affect gene
expression and cellular physiology.
Design Type(s) parallel group design • RNA Interference
Measurement Type(s) transcription proﬁling assay
Technology Type(s) DNA microarray
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Background & Summary
Jumonji domain-containing proteins are iron- and 2-oxoglutarate-dependent oxygenases that act on
diverse substrates including proteins, nucleic acids and small molecules1,2. These enzymes either
hydroxylate or demethylate their substrates in an oxygen-dependent manner. Many JmjC domain
proteins play a key role in the epigenetic regulation of mammalian development and of diseases such as
cancer2,3.
Phylogenetic analysis classiﬁes the Jumonji domain containing proteins into several subgroups3. One
subgroup comprises the asparaginyl hydroxylase FIH4,5, the ribosomal hydroxylases MINA53 and
NO66 (ref. 6) , the lysyl hydroxylase JMJD4 (ref. 7), the lysine demethylase/hydroxylase JMJD5 (refs 8,9) ,
the lysyl hydroxylase/arginine demethylase JMJD6 (refs 10,11) , the tRNA hydroxylase TYW5 (ref. 12),
and the enzymatically uncharacterized proteins JMJD8 and HSPBAP1. Although these enzymes share the
conserved JmjC domain with the histone lysine demethylases, they generally lack chromatin-binding
domain, indicating potential functions other than modifying histones.
Among the members of this functionally diverse subgroup, JMJD6 was recently characterized as a
crucial regulator for gene expression at the level of histone modiﬁcation10,13, transcriptional elongation14
and RNA splicing11,15,16. Jmjd6-deﬁcient mice show various developmental defects and perinatal
lethality17,18. Moreover, JMJD6 is required for angiogenesis15, adipocyte differentiation19 and T cell
proliferation20. Elevation of JMJD6 expression has been observed in breast21,22, lung23, colon24, and oral
cancer25. Depletion of JMJD6 by RNA interference reduced the proliferation of human cancer cell
lines21,24. Therefore, JMJD6 is essential for cellular proliferation and differentiation. In contrast, the
paralog protein JMJD4 that shares 34% sequence identity with JMJD6 was shown to be involved in
translational termination by hydroxylating the translational termination factor eRF1 (ref. 7). Other
biological functions of JMJD4 have not been demonstrated.
We conducted a loss-of-function study using an RNA interference approach to reduce the levels of
endogenous JMJD6 and JMJD4 in proliferating mouse NIH3T3 ﬁbroblasts. We found that depletion of
either JMJD6 or JMJD4 alone signiﬁcantly reduced cell proliferation. In order to determine whether and
how these JmjdC domain proteins affect gene expression on a global scale, we performed gene expression
proﬁling on the JMJD6 and JMJD4 knockdown NIH3T3 cells using the Affymetrix Exon Arrays. In this
report, we provide a detailed description of the gene expression proﬁling datasets.
Methods
The scheme of the experimental procedures is presented in Fig. 1.
Cell culture
The mouse NIH3T3 ﬁbroblast cell line was maintained in DMEM high glucose medium (Invitrogen)
containing 10% calf serum (Sigma) and 100 Uml−1 penicillin/streptomycin (Invitrogen). Human 293T
cells were maintained in DMEM high glucose medium containing 10% fetal calf serum (Sigma) and
100 Uml−1 penicillin/streptomycin (Invitrogen). To evaluate cell proliferation, 1 × 105 cells were
seeded in 6-well plates, and the number of viable cells was counted every other day with a
hemocytometer.
Figure 1. The scheme of the experimental design.
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Plasmid construction and virus transduction
The preparation of small hairpin RNA (shRNA) lentiviral constructs was performed as previously
described (Campeau, 2009). The shJMJD6 target sequence is 5′-GCTGACACCCAGAGAACAA-3′. The
shJMJD4 target sequence is GAAGAATTCTGGAGAGCAT. The control shRNA sequence is
TGGCGGCGAGTGAAGTACGTGATAA. The shRNA lentiviral constructs were co-transfected with
pLP1, pLP2 and pVSVG packaging vectors into 293T cells with Lipofectamine 2000 reagent (Invitrogen).
The viral supernatant was harvested after 48 h incubation and ﬁltered through a 0.45 μm syringe ﬁlter
(Millipore). To infect NIH3T3 cells, one million cells were incubated with 2 ml of the ﬁltered viral
supernatant supplemented with 4 μg ml−1 of polybrene (Sigma) for 48 h. The infected cells were
subsequently selected in media containing 2.5 μg ml−1 puromycin (Invitrogen) for 7 days.
RNA isolation and real-time qPCR analysis
One million cells were plated overnight in 10 cm culture dishes. The cells were washed with 5 ml cold PBS
and then lysed directly in the culture dish by adding 1 ml of TRIzol reagent (Invitrogen). Total RNA was
isolated from TRIzol lysates using RNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. An on-column DNAse digestion step is included in this protocol. cDNA was prepared from
1 μg of total RNA by Superscript III reverse transcriptase kit (Invitrogen). Quantitative PCR was
performed on a StepOne Plus real-time PCR machine with Fast SYBR Green Master mix (Applied
Biosystems). The relative gene expression levels were calculated as 2^ (CtEef1a1−Ctgene) and were
normalized to the scrambled shRNA control as indicated. The primers are listed below:
Eef1a1 (forward): 5′-AGCTTCTCTGACTACCCTCCACTT-3′
Eef1a1 (reverse): 5′-GACCGTTCTTCCACCACTGATT-3′
Jmjd6 (forward): 5′-GTTCCAGCTCGTCAGACTCG-3′
Jmjd6 (reverse): 5′-TGCCCCTAAGACATGACCAC-3′
Jmjd4 (forward): 5′-TCCTGCTGGAATGTCGCACCTGT-3′
Jmjd4 (reverse): 5′-ACCCCAAATAGGGACCGGAGGC-3′
Microarray analysis
The RNA samples were processed at the Genomics Core Facility of UMass Medical School. RNA quantity
and quality were assessed using an Agilent Bioanalyzer 2100. cDNA was synthesized from 500 ng RNA
using the Ambion WT kit (Life Technologies) and the single stranded cDNA was prepared using the
Affymetrix GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer’s instructions.
The labeled mix was hybridized to GeneChip Mouse Exon 1.0 ST Array (Affymetrix) in the Gene Chip
Hybridization Oven 640 overnight. Probe intensities were measured using the Affymetrix GeneChip
Scanner 3000 7G. The probe cell intensity data (CEL) from GeneChip Mouse Exon 1.0 ST Arrays was
analyzed in the Affymetrix Expression Console software to generate CHP ﬁles using the Robust Multichip
Analysis (RMA)-sketch algorithm workﬂow. The transcript structure conﬁdence levels for both gene and
exon level analyses were set as Core, which limits analysis to exon-level probe sets that map to BLAT
alignments of mRNA with annotated full-length coding sequence (CDS) regions. Differentially expressed
genes and exons were identiﬁed by Transcriptome Analysis Console (TAC) 3.0 software (Affymetrix).
Data Records
Gene expression proﬁling on RNA samples collected from the control shRNA-treated (shCtrl_R1 and
shCtrl_R2), JMJD6 knockdown (shJMJD6_R1 and shJMJD6_R2), JMJD4 knockdown (shJMJD4_R1
and shJMJD4_R2) cells was performed using GeneChip Mouse Exon 1.0 ST Arrays. Two biological
replicates were performed. Both gene level and exon level expression were analyzed. All samples and
datasets are described in Table 1. The primary data are available at the NCBI Gene Expression Omnibus
(GEO) under the accession numbers GSE76758 (Data Citation 1).
Technical Validation
Conﬁrmation of the shRNA-mediated knockdown
The shRNA-mediated knockdown reduced cell proliferation is shown in Fig. 2a. The signal intensity values of
expression from the Jmjd6 and Jmjd4 genes in the microarray datasets are shown in Fig. 2b. The expression
levels from the endogenous Jmjd6 and Jmjd4 genes were conﬁrmed by real-time qPCR and are shown in Fig. 2c.
Quality control of microarray data
The probe cell intensity values in each individual array were generated from the Affymetrix Expression
Console software and are presented in the box plot (Fig. 3a). The data indicate that the probe cell
intensities from the individual arrays were similar. The reproducibility of the microarray results is shown
by the correlation analyses on the biological replicates. The correlation between the samples at the gene
level (Fig. 3b) and at the exon level (Fig. 3c) are presented in the scatter plots with the squared Pearson
correlation coefﬁcient (R2). All pairs of biological replicates have very high correlation (R2≥ 0.98 for gene
level analysis; R2≥ 0.96 for exon level analysis). Knockdown of JMJD4 has more profound impact on
gene expression than knockdown of JMJD6 (R2= 0.97 versus R2= 0.99 for gene level analysis; R2= 0.96
versus R2= 0.98 for exon level analysis).
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Sample name Cell line Description Dataset
shCtrl_R1 NIH3T3 Control shRNA-treated, biological replicate 1, gene level analysis GSM2037236
shCtrl_R1 NIH3T3 Control shRNA-treated, biological replicate 1, exon level analysis GSM2037237
shCtrl_R2 NIH3T3 Control shRNA-treated, biological replicate 2, gene level analysis GSM2037238
shCtrl_R2 NIH3T3 Control shRNA-treated, biological replicate 2, exon level analysis GSM2037239
shJMJD6_R1 NIH3T3 JMJD6 shRNA-treated, biological replicate 1, gene level analysis GSM2037240
shJMJD6_R1 NIH3T3 JMJD6 shRNA-treated, biological replicate 1, exon level analysis GSM2037241
shJMJD6_R2 NIH3T3 JMJD6 shRNA-treated, biological replicate 2, gene level analysis GSM2037242
shJMJD6_R2 NIH3T3 JMJD6 shRNA-treated, biological replicate 2, exon level analysis GSM2037243
shJMJD4_R1 NIH3T3 JMJD4 shRNA-treated, biological replicate 1, gene level analysis GSM2037244
shJMJD4_R1 NIH3T3 JMJD4 shRNA-treated, biological replicate 1, exon level analysis GSM2037245
shJMJD4_R2 NIH3T3 JMJD4 shRNA-treated, biological replicate 2, gene level analysis GSM2037246
shJMJD4_R2 NIH3T3 JMJD4 shRNA-treated, biological replicate 2, exon level analysis GSM2037247
Table 1. Sample and Dataset Descriptions.
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Figure 2. The effects of shRNA-mediated knockdown of JMJD6 or JMJD4 on mouse NIH3T3 ﬁbroblast
proliferation. (a) The cell proliferation curve of the control shRNA-treated (shCtrl), JMJD6 knockdown
(shJMJD6), and JMJD4 knockdown (shJMJD4) mouse NIH3T3 ﬁbroblasts. (b) The signal intensity of
expression from the Jmjd6 and Jmdj4 genes from each individual array. (c) The relative expression levels from
the endogenous Jmjd6 and Jmdj4 genes in each sample were determined by real-time qPCR analysis. The value
of the shCtrl_R1 sample was set as 1.
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Usage Notes
The full quality control report can be accessed using the Affymetrix Expression Console software. The
differentially expressed genes and exons can be identiﬁed using the Affymetrix Transcriptome Analysis
Console software.
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